Radiotherapy in brain metastases from EGFR-mutated non-small cell lung cancer

Epidermal growth factor receptor (EGFR) mutations are present in 20–40% of non-small cell lung cancers (NSCLCs). Brain metastasis (BM) is more common in EGFR-mutated NSCLC (25–45%) compared to EGFR wild-type (15–30%). First and second-generation tyrosine kinase inhibitors (TKIs), such as erlotinib a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Thorac Dis
Hlavní autoři: Bhandari, Shruti, Dunlap, Neal, Kloecker, Goetz
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2021
Témata:
Review Article on Radiotherapy for Brain Metastases from Lung Cancer
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8182502/
https://ncbi.nlm.nih.gov/pubmed/34164215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd-2019-rbmlc-04
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky